tiprankstipranks
Trending News
More News >
BioNTech SE (BNTX)
NASDAQ:BNTX
US Market

BioNTech SE (BNTX) Ratios

Compare
4,592 Followers

BioNTech SE Ratios

BNTX's free cash flow for Q1 2025 was €0.54. For the 2025 fiscal year, BNTX's free cash flow was decreased by € and operating cash flow was €-2.25. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
7.43 9.43 7.43 4.33 2.75
Quick Ratio
7.28 9.26 7.28 4.18 2.64
Cash Ratio
4.70 5.63 4.70 0.49 2.00
Solvency Ratio
2.96 0.40 2.96 2.63 0.05
Operating Cash Flow Ratio
4.60 2.59 4.60 0.26 -0.02
Short-Term Operating Cash Flow Coverage
377.15 191.15 377.15 6.85 -1.48
Net Current Asset Value
€ 18.70B€ 16.77B€ 18.70B€ 11.14B€ 720.12M
Leverage Ratios
Debt-to-Assets Ratio
<0.01 <0.01 <0.01 0.02 0.10
Debt-to-Equity Ratio
0.01 0.01 0.01 0.03 0.18
Debt-to-Capital Ratio
0.01 0.01 0.01 0.02 0.15
Long-Term Debt-to-Capital Ratio
<0.01 <0.01 <0.01 0.01 0.14
Financial Leverage Ratio
1.16 1.14 1.16 1.33 1.69
Debt Service Coverage Ratio
162.25 39.12 162.25 75.75 0.75
Interest Coverage Ratio
668.93 1.21K 668.93 2.83K -1.27
Debt to Market Cap
<0.01 <0.01 <0.01 <0.01 0.02
Interest Debt Per Share
0.95 0.91 0.95 1.26 1.30
Net Debt to EBITDA
-1.10 -8.31 -1.10 -0.09 9.23
Profitability Margins
Gross Profit Margin
73.82%84.29%73.82%79.66%-46.03%
EBIT Margin
71.08%31.26%71.08%78.66%-29.81%
EBITDA Margin
71.79%36.07%71.79%79.06%-21.79%
Operating Profit Margin
73.03%18.08%73.03%80.54%-17.09%
Pretax Profit Margin
74.83%31.06%74.83%79.29%-30.23%
Net Profit Margin
54.50%24.36%54.50%54.24%3.15%
Continuous Operations Profit Margin
54.50%24.36%54.50%54.24%3.15%
Net Income Per EBT
72.83%78.43%72.83%68.41%-10.43%
EBT Per EBIT
102.46%171.80%102.46%98.45%176.91%
Return on Assets (ROA)
40.53%4.04%40.53%65.02%0.66%
Return on Equity (ROE)
47.04%4.60%47.04%86.54%1.11%
Return on Capital Employed (ROCE)
62.19%3.30%62.19%123.76%-4.81%
Return on Invested Capital (ROIC)
45.21%2.58%45.21%83.78%0.50%
Return on Tangible Assets
40.91%4.26%40.91%65.86%0.71%
Earnings Yield
27.64%4.05%27.64%18.61%0.10%
Efficiency Ratios
Receivables Turnover
2.42 1.77 2.42 1.53 0.00
Payables Turnover
22.20 1.69 22.20 24.13 6.89
Inventory Turnover
10.31 1.68 10.31 7.68 10.99
Fixed Asset Turnover
21.08 3.93 21.08 36.47 1.48
Asset Turnover
0.74 0.17 0.74 1.20 0.21
Working Capital Turnover Ratio
1.13 0.21 1.13 3.00 0.65
Cash Conversion Cycle
169.63 208.75 169.63 270.53 -19.78
Days of Sales Outstanding
150.67 206.50 150.67 238.15 0.00
Days of Inventory Outstanding
35.40 217.67 35.40 47.51 33.23
Days of Payables Outstanding
16.44 215.42 16.44 15.13 53.01
Operating Cycle
186.07 424.17 186.07 285.66 33.23
Cash Flow Ratios
Operating Cash Flow Per Share
55.81 22.33 55.81 3.65 -0.06
Free Cash Flow Per Share
54.31 19.39 54.31 3.02 -0.42
CapEx Per Share
1.49 2.93 1.49 0.63 0.36
Free Cash Flow to Operating Cash Flow
0.97 0.87 0.97 0.83 7.34
Dividend Paid and CapEx Coverage Ratio
16.19 7.61 16.19 5.78 -0.16
Capital Expenditure Coverage Ratio
37.37 7.61 37.37 5.78 -0.16
Operating Cash Flow Coverage Ratio
63.98 24.52 63.98 2.95 -0.06
Operating Cash Flow to Sales Ratio
0.78 1.41 0.78 0.05 -0.03
Free Cash Flow Yield
38.71%20.31%38.71%1.33%-0.63%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
3.62 24.69 3.62 5.37 1.03K
Price-to-Sales (P/S) Ratio
1.97 6.02 1.97 2.91 32.56
Price-to-Book (P/B) Ratio
1.70 1.13 1.70 4.65 11.45
Price-to-Free Cash Flow (P/FCF) Ratio
2.58 4.92 2.58 75.19 -158.75
Price-to-Operating Cash Flow Ratio
2.51 4.28 2.51 62.17 -1.17K
Price-to-Earnings Growth (PEG) Ratio
-0.27 -0.27 -0.27 <0.01 -9.65
Price-to-Fair Value
1.70 1.13 1.70 4.65 11.45
Enterprise Value Multiple
1.65 8.37 1.65 3.59 -140.19
Enterprise Value
20.47B 11.53B 20.47B 53.93B 14.73B
EV to EBITDA
1.65 8.37 1.65 3.59 -140.19
EV to Sales
1.18 3.02 1.18 2.84 30.55
EV to Free Cash Flow
1.55 2.47 1.55 73.30 -148.95
EV to Operating Cash Flow
1.51 2.15 1.51 60.61 -1.09K
Tangible Book Value Per Share
81.53 79.30 81.53 47.92 5.13
Shareholders’ Equity Per Share
82.43 84.15 82.43 48.74 5.83
Tax and Other Ratios
Effective Tax Rate
0.27 0.22 0.27 0.32 1.10
Revenue Per Share
71.15 15.87 71.15 77.77 2.05
Net Income Per Share
38.78 3.87 38.78 42.18 0.06
Tax Burden
0.73 0.78 0.73 0.68 -0.10
Interest Burden
1.05 0.99 1.05 1.01 1.01
Research & Development to Revenue
<0.01 0.47 <0.01 <0.01 1.34
SG&A to Revenue
0.03 0.13 0.03 0.01 0.19
Stock-Based Compensation to Revenue
<0.01 0.01 <0.01 <0.01 0.07
Income Quality
1.05 4.53 1.05 0.06 0.09
Currency in EUR
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis